Skip to content

SPP closes at 5pm AWST Wed 25th Nov 2026  Learn more    

Proteomics signs PromarkerD agreement with US big pharma

Building on the company’s recent licensing deals for PromarkerD as a predictive test for diabetic kidney disease, Proteomics International is pleased to announce it has signed a research collaboration agreement with Janssen Research & Development LLC, for diabetic kidney disease treatment research.

Media release